EUVIMEDEUVIMED entdecken
Crossref

Circulating MicroRNA Expression in Glioblastoma: A Promising Diagnostic Panel

Vincenzo Macaione, Francesca Graziano, Francesca Polito, Gianluca Scalia, Laura Licitri, Marieme Khouyyi, Margherita Maria Torre, Selene Francesca Anna Drago, Alba Migliorato, Giovanni Federico Nicoletti, Salvatore Massimiliano Cardali, Domenico La Torre und 1 weitere

Oncology · 2025

DOI: 10.1159/000548121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology, 2025. Verfasst von Vincenzo Macaione und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy, vmacaione@unime.it. Hauptthemen laut MEDLINE: Glioblastoma, MicroRNAs, Biomarkers, Tumor, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Among malignant brain tumors, glioblastoma (GB) is one of the most common. An early diagnosis would benefit the prognosis: in this regard, the search for sensitive and specific biomarkers is particularly active. In fact, liquid biopsy has been proposed by many researchers as a valid and repeatable method of studying GB. Among the biomarkers researched in blood patients, microRNAs (miRNAs) are among the most encouraging. The aim of our research was to select blood miRNAs overexpressed in GB patients to establish a reliable biomarker panel for pathology.

Methods

We studied blood expression of 14 miRNAs in 30 subjects with GB, before and after surgery, and 30 healthy controls.

Results

Statistical analysis allowed us to select a panel of 3 miRNAs (miR-340-5p, miR-369-3p, miR-486-5p) that are overexpressed in GB patients.

Conclusion

Our results showed that simultaneous measurement of circulating miR-340-5p, miR-369-3p, and miR-486-5p represents a promising biomarker for the diagnosis and follow-up of GB patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaMicroRNAsBiomarkers, TumorBrain NeoplasmsCirculating MicroRNAHumansFemaleMaleMiddle AgedCase-Control StudiesAgedAdultPrognosisGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

AstrocytomaBiomarkersGlioblastomaLiquid biopsyMicroRNA

Substanzen

MicroRNAsBiomarkers, TumorCirculating MicroRNAMIRN340 microRNA, humanMIRN486 microRNA, human

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy, vmacaione@unime.it.
  • Department of Head and Neck Surgery, Garibaldi Hospital of Catania, Catania, Italy.
  • Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
  • Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.
  • Departement of Medical and Surgical Sciences, University Magna Graecia, Catanzaro, Italy.

Zitieren

APA

Macaione, V., Graziano, F., Polito, F., Scalia, G., Licitri, L., Khouyyi, M., Torre, M. M., Drago, S. F. A., Migliorato, A., Nicoletti, G. F., Cardali, S. M., La Torre, D., & Aguennouz, M. A. H. (2025). Circulating MicroRNA Expression in Glioblastoma: A Promising Diagnostic Panel. Oncology. https://doi.org/10.1159/000548121

Vancouver

Macaione V, Graziano F, Polito F, Scalia G, Licitri L, Khouyyi M, et al. Circulating MicroRNA Expression in Glioblastoma: A Promising Diagnostic Panel. Oncology. 2025. doi:10.1159/000548121

BibTeX
@article{Macaione2025,
  author = {Macaione, Vincenzo and Graziano, Francesca and Polito, Francesca and Scalia, Gianluca and Licitri, Laura and Khouyyi, Marieme and Torre, Margherita Maria and Drago, Selene Francesca Anna and Migliorato, Alba and Nicoletti, Giovanni Federico and Cardali, Salvatore Massimiliano and La Torre, Domenico and Aguennouz, M Apos Hammed},
  title = {Circulating MicroRNA Expression in Glioblastoma: A Promising Diagnostic Panel},
  journal = {Oncology},
  year = {2025},
  doi = {10.1159/000548121}
}
Kostenlos starten →